Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?
- PMID: 25201009
- DOI: 10.1007/s00259-014-2908-2
Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct?
Comment on
-
¹⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study.Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1482-91. doi: 10.1007/s00259-014-2774-y. Epub 2014 Apr 30. Eur J Nucl Med Mol Imaging. 2014. PMID: 24781870
-
Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot?Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1479-81. doi: 10.1007/s00259-014-2794-7. Eur J Nucl Med Mol Imaging. 2014. PMID: 24824461 No abstract available.
Similar articles
-
Differentiated thyroid cancer incidentally detected by ¹⁸F-FDG PET/CT: patient's future in a hot-spot?Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1479-81. doi: 10.1007/s00259-014-2794-7. Eur J Nucl Med Mol Imaging. 2014. PMID: 24824461 No abstract available.
-
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.Thyroid. 2015 Apr;25(4):437-44. doi: 10.1089/thy.2014.0320. Epub 2015 Mar 16. Thyroid. 2015. PMID: 25633259
-
Primary squamous cell carcinoma of the thyroid on FDG PET/CT.Clin Nucl Med. 2014 Nov;39(11):1014-6. doi: 10.1097/RLU.0000000000000511. Clin Nucl Med. 2014. PMID: 24999700
-
PET/CT imaging of thyroid cancer.Clin Nucl Med. 2011 Dec;36(12):e180-5. doi: 10.1097/RLU.0b013e3182291d03. Clin Nucl Med. 2011. PMID: 22064103 Review.
-
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview.Eur Arch Otorhinolaryngol. 2013 May;270(6):1783-7. doi: 10.1007/s00405-012-2205-2. Epub 2012 Oct 2. Eur Arch Otorhinolaryngol. 2013. PMID: 23053387 Review.
Cited by
-
Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System.World J Nucl Med. 2016 May-Aug;15(2):130-3. doi: 10.4103/1450-1147.176883. World J Nucl Med. 2016. PMID: 27134564 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical